Investigational Drug Information for Resminostat
✉ Email this page to a colleague
What is the development status for investigational drug Resminostat?
Resminostat is an investigational drug.
There have been 6 clinical trials for Resminostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Sezary Syndrome, and Mycosis Fungoides. The leading clinical trial sponsors are 4SC AG, Yakult Honsha Co., LTD, and [disabled in preview].
Summary for Resminostat
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 354 |
| WIPO Patent Applications | 322 |
| Japanese Patent Applications | 111 |
| Clinical Trial Progress | Phase 2 (2009-12-01) |
| Vendors | 37 |
Recent Clinical Trials for Resminostat
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat | 4SC AG | Phase 1 |
| Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) | 4SC AG | Phase 2 |
| Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) | Yakult Honsha Co., LTD | Phase 1/Phase 2 |
Clinical Trial Summary for Resminostat
Top disease conditions for Resminostat
Top clinical trial sponsors for Resminostat
US Patents for Resminostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
